A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.
Rugo HS, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN.
Rugo HS, et al. Among authors: park jw.
Breast Cancer Res Treat. 2012 Jul;134(1):13-20. doi: 10.1007/s10549-011-1918-z. Epub 2011 Dec 24.
Breast Cancer Res Treat. 2012.
PMID: 22198412
Free PMC article.
Clinical Trial.